Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
UK Body Urges Action On Licensing Delays As MHRA Unveils Guidance For Established Products
Regulator Aims To Shorten Timeframes For Assessment Of Established Medicines
Mar 06 2024
•
By
Dave Wallace
Speedier approvals are needed to clear the MHRA backlog • Source: Shutterstock
More from Regulation
More from Policy & Regulation